Canaccord Genuity Starts TELA Bio, Inc. (TELA) at Buy

Go back to Canaccord Genuity Starts TELA Bio, Inc. (TELA) at Buy

JMP Securities Starts TELA Bio, Inc. (TELA) at Market Outperform

December 3, 2019 7:47 AM EST

JMP Securities analyst David Turklay initiates coverage on TELA Bio, Inc. (NASDAQ: TELA) with a Market Outperform rating and a price target of $22.00.

The analyst comments "Rarely does one see new medical solutions that provide significant benefits to essentially all constituents (i.e.,... More

Piper Jaffray Starts TELA Bio, Inc. (TELA) at Overweight

December 3, 2019 4:32 AM EST

Piper Jaffray analyst Matt O/Briend initiates coverage on TELA Bio, Inc. (NASDAQ: TELA) with a Overweight rating and a price target of $17.00.


For an analyst ratings summary and ratings history on TELA Bio, Inc.... More

Jefferies Starts TELA Bio, Inc. (TELA) at Buy

December 3, 2019 4:32 AM EST

Jefferies analyst Raj Denhoy initiates coverage on TELA Bio, Inc. (NASDAQ: TELA) with a Buy rating and a price target of $23.00.


For an analyst ratings summary and ratings history on TELA Bio, Inc.... More